Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dosing and postoperative analgesic demand in gynecologic laparoscopic surgery
ChiCTR2300073287Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative pain (3 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Dosage of analgesic drugs used by PCIA within 24 hours after operation. Started Sep 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300073287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073287.